Switch theme
Sign up to access all valuation multiples
Instituto de Diagnostico SA, through Clinica Indisa, provides medical and healthcare services. It offers clinical services in the areas of general surgery, traumatology, urology, maternity, dialysis, cardiovascular, odontology, gynecology and obstetrics, blood bank facility, maternity facility, critical patient unit, and various other medical-related services and facilities. Along with its subsidiaries, the company operates in the following segments; Hospitalization which generates maximum revenue and corresponds to services provided to patients who are hospitalized and spend days in bed; Outpatient corresponds to services that do not involve occupation of bed days; and Others corresponds to the parking rental and services category maintenance.
1961
3.1K+
Last FY Revenue $247M
Last FY EBITDA $17.1M
$483M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Instituto de Diagnostico achieved revenue of $247M and an EBITDA of $17.1M.
Instituto de Diagnostico expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Instituto de Diagnostico valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $247M | XXX | XXX | XXX |
| Gross Profit | XXX | $60.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 24% | XXX | XXX | XXX |
| EBITDA | XXX | $17.1M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 7% | XXX | XXX | XXX |
| EBIT | XXX | $15.1M | XXX | XXX | XXX |
| EBIT Margin | XXX | 6% | XXX | XXX | XXX |
| Net Profit | XXX | $7.5M | XXX | XXX | XXX |
| Net Margin | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | $85.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Instituto de Diagnostico's stock price is CLP 2607 (or $3).
Instituto de Diagnostico has current market cap of CLP 377B (or $390M), and EV of CLP 467B (or $483M).
See Instituto de Diagnostico trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $483M | $390M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Instituto de Diagnostico has market cap of $390M and EV of $483M.
Instituto de Diagnostico's trades at 2.0x EV/Revenue multiple, and 28.3x EV/EBITDA.
Equity research analysts estimate Instituto de Diagnostico's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Instituto de Diagnostico's P/E ratio is not available.
See valuation multiples for Instituto de Diagnostico and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $390M | XXX | $390M | XXX | XXX | XXX |
| EV (current) | $483M | XXX | $483M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 28.3x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 31.9x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 51.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 28.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInstituto de Diagnostico's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $15K for the same period.
Instituto de Diagnostico's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Instituto de Diagnostico's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Instituto de Diagnostico and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $15K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Instituto de Diagnostico acquired XXX companies to date.
Last acquisition by Instituto de Diagnostico was XXXXXXXX, XXXXX XXXXX XXXXXX . Instituto de Diagnostico acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Instituto de Diagnostico founded? | Instituto de Diagnostico was founded in 1961. |
| Where is Instituto de Diagnostico headquartered? | Instituto de Diagnostico is headquartered in Chile. |
| How many employees does Instituto de Diagnostico have? | As of today, Instituto de Diagnostico has 3.1K+ employees. |
| Is Instituto de Diagnostico publicy listed? | Yes, Instituto de Diagnostico is a public company listed on SGO. |
| What is the stock symbol of Instituto de Diagnostico? | Instituto de Diagnostico trades under INDISA ticker. |
| When did Instituto de Diagnostico go public? | Instituto de Diagnostico went public in 1982. |
| Who are competitors of Instituto de Diagnostico? | Similar companies to Instituto de Diagnostico include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Instituto de Diagnostico? | Instituto de Diagnostico's current market cap is $390M |
| Is Instituto de Diagnostico profitable? | Yes, Instituto de Diagnostico is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
